-
公开(公告)号:US5670516A
公开(公告)日:1997-09-23
申请号:US456439
申请日:1995-06-01
申请人: M. Brian Arnold , Nancy K. Augenstein , William H. W. Lunn , Paul L. Ornstein , Darryle D. Schoepp
发明人: M. Brian Arnold , Nancy K. Augenstein , William H. W. Lunn , Paul L. Ornstein , Darryle D. Schoepp
IPC分类号: A61K31/47 , A61K31/472 , A61K31/4725 , A61P1/08 , A61P9/10 , A61P13/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/02 , A61P43/00 , C07D217/16 , C07D217/26 , C07D401/06 , C07D401/12 , C07D413/06 , C07D413/12 , C07D417/06 , C07D417/12 , C07F9/6524 , C07D215/14
CPC分类号: C07D401/06 , C07D217/26 , C07D401/12 , C07D413/06 , C07D417/06 , C07F9/6524
摘要: This invention provides novel decahydroisoquinoline compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological disorders. This invention also provides synthetic methods for preparing decahydroisoquinolines, as well as, novel intermediates in the synthesis thereof.
摘要翻译: 本发明提供了可用作兴奋性氨基酸受体拮抗剂和神经障碍治疗的新型十氢异喹啉化合物。 本发明还提供用于制备十氢异喹啉的合成方法,以及其合成中的新型中间体。
-
公开(公告)号:US5399696A
公开(公告)日:1995-03-21
申请号:US111747
申请日:1993-08-25
IPC分类号: A61K31/47 , A61K31/472 , A61K31/4725 , A61P1/08 , A61P9/10 , A61P13/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/02 , A61P43/00 , C07D217/16 , C07D217/26 , C07D401/06 , C07D401/12 , C07D413/06 , C07D413/12 , C07D417/06 , C07D417/12 , C07F9/6524 , C07D217/02
CPC分类号: C07D401/06 , C07D217/26 , C07D401/12 , C07D413/06 , C07D417/06 , C07F9/6524
摘要: This invention provides novel decahydroisoquinoline compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological disorders. This invention also provides synthetic methods for preparing decahydroisoquinolines, as well as, novel intermediates in the synthesis thereof.
摘要翻译: 本发明提供了可用作兴奋性氨基酸受体拮抗剂和神经障碍治疗的新型十氢异喹啉化合物。 本发明还提供用于制备十氢异喹啉的合成方法,以及其合成中的新型中间体。
-
公开(公告)号:US5648492A
公开(公告)日:1997-07-15
申请号:US456577
申请日:1995-06-01
申请人: M. Brian Arnold , Carl F. Bertsch , Marvin M. Hansen , Allen R. Harkness , Bret Huff , Michael J. Martinelli , Paul L. Ornstein
发明人: M. Brian Arnold , Carl F. Bertsch , Marvin M. Hansen , Allen R. Harkness , Bret Huff , Michael J. Martinelli , Paul L. Ornstein
IPC分类号: A61K31/47 , A61K31/472 , A61K31/4725 , A61P1/08 , A61P9/10 , A61P13/02 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/02 , A61P43/00 , C07D217/16 , C07D217/26 , C07D401/06 , C07D401/12 , C07D413/06 , C07D413/12 , C07D417/06 , C07D417/12 , C07F9/6524 , C07D215/14
CPC分类号: C07D401/06 , C07D217/26 , C07D401/12 , C07D413/06 , C07D417/06 , C07F9/6524
摘要: This invention provides novel decahydroisoquinoline compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological disorders. This invention also provides synthetic methods for preparing decahydroisoquinolines, as well as, novel intermediates in the synthesis thereof.
摘要翻译: 本发明提供了可用作兴奋性氨基酸受体拮抗剂和神经障碍治疗的新型十氢异喹啉化合物。 本发明还提供用于制备十氢异喹啉的合成方法,以及其合成中的新型中间体。
-
公开(公告)号:US5717109A
公开(公告)日:1998-02-10
申请号:US500303
申请日:1995-07-10
申请人: M. Brian Arnold , Thomas J. Bleisch , David R. Helton , Mary Jeanne Kallman , Paul L. Ornstein , Darryle D. Schoepp , Joseph P. Tizzano
发明人: M. Brian Arnold , Thomas J. Bleisch , David R. Helton , Mary Jeanne Kallman , Paul L. Ornstein , Darryle D. Schoepp , Joseph P. Tizzano
IPC分类号: C07C62/12 , C07C62/18 , C07C62/22 , C07C62/26 , C07D211/34 , C07D233/76 , C07D311/80 , A61K31/19 , C07C207/00 , C07C229/00 , C07D209/04 , C07D333/22 , C07C101/20 , C07D31/80
CPC分类号: C07D233/76 , C07C62/12 , C07C62/18 , C07C62/22 , C07C62/26 , C07D211/34 , C07D311/80
摘要: The present invention provides compounds of formula ##STR1## in which R represents an organic group, or a pharmaceutically acceptable metabolically labile ester or amide thereof, or a pharmaceutically acceptable salt thereof, which are useful as antagonists of one or more of the actions of L-glutamate at metabotropic excitatory amino acid receptors.
摘要翻译: 本发明提供式I的化合物,其中R代表有机基团,或其药学上可接受的代谢不稳定的酯或酰胺或其药学上可接受的盐,其可用作一种或多种以下作用的拮抗剂: 代谢型兴奋性氨基酸受体中的L-谷氨酸。
-
-
-